Microarray assays can measure the transcriptional effects of changes in gene function under different conditions. They can reveal genes that characterize tissue type, developmental stage ...

Figure 1. (Left) examples of flexible VaxArray microarray-based assay designs, with 5’CapQ assay schematic highlighted, (Center) a schematic of a single VaxArray microarray slide with 16 ...

AliveDx’s CE mark for the systematic autoimmune rheumatic disease (SARD) assay marks its fifth approval in the past 18 months.

The MammaPrint™ assay (Agendia BV, The Netherlands) is the first fully commercialized microarray-based multigene assay designed to individualize treatment for patients with breast cancer.

FRIZ Biochem of Munich is developing two new electrochemical DNA microarray readout products that will use ... The first, EDDA (electrically detected displacement assay), will be available by the end ...

Our in-house microarray experts will collaborate with you from initial assay optimisation and throughout the lifetime of your instrument. Instruments ship worldwide from our ISO13485:2016 compliant ...

For Celiac Disease, the multiplex assay is designed to rapidly detect and identify up to 425 disease markers per hour. Seamless, microarray-internal calibration and quality control as well as ...

AliveDx seeks US FDA 510(k) premarket approval for MosaiQ AiPlex CD multiplex microarray: Eysins, Switzerland Tuesday, February 11, 2025, 12:00 Hrs [IST] AliveDx, an established c ...

The TargetPrint assay determines the ER, PR and HER2 mRNA levels using eight subarrays on Agendia's new High-Density Microarray Chip. The TargetPrint assay has been validated against FDA-approved ...

The MosaiQ AiPlex CD is designed to improve the  accuracy and speed of celiac disease diagnosis while simplifying laboratory workflows EYSINS, Switzerland , Feb.